These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 19218588)
1. Aberrant DNA methylation status in human uterine leiomyoma. Yamagata Y; Maekawa R; Asada H; Taketani T; Tamura I; Tamura H; Ogane J; Hattori N; Shiota K; Sugino N Mol Hum Reprod; 2009 Apr; 15(4):259-67. PubMed ID: 19218588 [TBL] [Abstract][Full Text] [Related]
2. Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. Maekawa R; Sato S; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Takaki E; Nakai A; Sugino N PLoS One; 2013; 8(6):e66632. PubMed ID: 23818951 [TBL] [Abstract][Full Text] [Related]
3. Disease-dependent differently methylated regions (D-DMRs) of DNA are enriched on the X chromosome in uterine leiomyoma. Maekawa R; Yagi S; Ohgane J; Yamagata Y; Asada H; Tamura I; Sugino N; Shiota K J Reprod Dev; 2011 Oct; 57(5):604-12. PubMed ID: 21685710 [TBL] [Abstract][Full Text] [Related]
4. Potential mechanisms of aberrant DNA hypomethylation on the x chromosome in uterine leiomyomas. Sato S; Maekawa R; Yamagata Y; Asada H; Tamura I; Lee L; Okada M; Tamura H; Sugino N J Reprod Dev; 2014 Mar; 60(1):47-54. PubMed ID: 24291816 [TBL] [Abstract][Full Text] [Related]
5. DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. Li S; Chiang TC; Richard-Davis G; Barrett JC; Mclachlan JA Gynecol Oncol; 2003 Jul; 90(1):123-30. PubMed ID: 12821352 [TBL] [Abstract][Full Text] [Related]
6. Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. Navarro A; Yin P; Monsivais D; Lin SM; Du P; Wei JJ; Bulun SE PLoS One; 2012; 7(3):e33284. PubMed ID: 22428009 [TBL] [Abstract][Full Text] [Related]
7. No evidence for the role of somatic mutations and promoter hypermethylation of FH gene in the tumorigenesis of nonsyndromic uterine leiomyomas. Vaidya S; Shaik NA; Latha M; Chava S; Mohiuddin K; Yalla A; Rao KP; Kodati VL; Hasan Q Tumour Biol; 2012 Oct; 33(5):1411-8. PubMed ID: 22528940 [TBL] [Abstract][Full Text] [Related]
9. Identification of uterine leiomyoma-specific marker genes based on DNA methylation and their clinical application. Sato S; Maekawa R; Yamagata Y; Tamura I; Lee L; Okada M; Jozaki K; Asada H; Tamura H; Sugino N Sci Rep; 2016 Aug; 6():30652. PubMed ID: 27498619 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation and gene hypermethylation of the 14-3-3 gamma in uterine leiomyoma. Jiang W; Luo H; Shen Z; Zhang W; Chen A; Zhu X Front Biosci (Landmark Ed); 2016 Jun; 21(6):1286-95. PubMed ID: 27100507 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of erythropoietin in uterine leiomyoma: implications in tumor growth. Asano R; Asai-Sato M; Miyagi Y; Mizushima T; Koyama-Sato M; Nagashima Y; Taguri M; Sakakibara H; Hirahara F; Miyagi E Am J Obstet Gynecol; 2015 Aug; 213(2):199.e1-8. PubMed ID: 25724399 [TBL] [Abstract][Full Text] [Related]
12. Does aberrant DNA methylation occur in human uterine leiomyomas? An attempt of genome-wide screening by MS-RDA. Cai LY; Izumi S; Abe M; Imura M; Yasugi T; Wakazono K; Ohnuki Y; Kondo A; Ushijima T Tokai J Exp Clin Med; 2011 Sep; 36(3):84-90. PubMed ID: 21932190 [TBL] [Abstract][Full Text] [Related]
13. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays. Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101 [TBL] [Abstract][Full Text] [Related]
14. Epigenomic and enhancer dysregulation in uterine leiomyomas. Mlodawska OW; Saini P; Parker JB; Wei JJ; Bulun SE; Simon MA; Chakravarti D Hum Reprod Update; 2022 Jun; 28(4):518-547. PubMed ID: 35199155 [TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor 1 messenger RNA expression and molecular evidence for del(7)(q22) in uterine leiomyomas. Sourla A; Polychronakos C; Zeng WR; Nepveu A; Kukuvitis A; Naud F; Koutsilieris M Cancer Res; 1996 Jul; 56(13):3123-8. PubMed ID: 8674071 [TBL] [Abstract][Full Text] [Related]
16. The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development. Yang Q; Mas A; Diamond MP; Al-Hendy A Reprod Sci; 2016 Feb; 23(2):163-75. PubMed ID: 25922306 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P450IA1 activity in human myometrium and uterine leiomyoma: influence of smoking. Lamminen S; Pyykkö K; Rorarius M; Tuimala R Toxicology; 1993 Oct; 83(1-3):41-8. PubMed ID: 8248949 [TBL] [Abstract][Full Text] [Related]
18. SATB2 and NGR1: potential upstream regulatory factors in uterine leiomyomas. Sato S; Maekawa R; Tamura I; Shirafuta Y; Shinagawa M; Asada H; Taketani T; Tamura H; Sugino N J Assist Reprod Genet; 2019 Nov; 36(11):2385-2397. PubMed ID: 31728810 [TBL] [Abstract][Full Text] [Related]
19. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors. Schwetye KE; Pfeifer JD; Duncavage EJ Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187 [TBL] [Abstract][Full Text] [Related]
20. Comparative expression of thioredoxin-1 in uterine leiomyomas and myometrium. Hou P; Zhao L; Li Y; Luo F; Wang S; Song J; Bai J Mol Hum Reprod; 2014 Feb; 20(2):148-54. PubMed ID: 24130091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]